Ignite Creation Date:
2024-05-05 @ 4:44 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00308087
Status:
TERMINATED
Last Update Posted:
2013-12-27
First Post:
2006-03-28
Brief Title:
Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma a Form of Non-Hodgkins Lymphoma
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
310421
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genzyme a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None